GE HealthCare Technologies Inc. (GEHC)

US — Healthcare Sector
Peers: TDOC  VEEV  TXG  PGNY  SDGR  DOCS  AMWL  GDRX 

Automate Your Wheel Strategy on GEHC

With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol GEHC
  • Rev/Share 43.6893
  • Book/Share 21.7768
  • PB 3.356
  • Debt/Equity 0.2064
  • CurrentRatio 0.9856
  • ROIC 0.1046

 

  • MktCap 32656358200.0
  • FreeCF/Share 2.6718
  • PFCF 26.7456
  • PE 14.5441
  • Debt/Assets 0.0565
  • DivYield 0.0019
  • ROE 0.2514

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade GEHC UBS Sell Neutral -- $73 May 5, 2025
Upgrade GEHC Goldman Neutral Buy $85 $100 March 11, 2025
Upgrade GEHC Jefferies Hold Buy $95 $103 Jan. 8, 2025
Downgrade GEHC UBS Neutral Sell $84 $74 Sept. 26, 2024
Upgrade GEHC BTIG Research Neutral Buy -- $100 Sept. 18, 2024
Initiation GEHC JP Morgan -- Neutral -- $90 Sept. 9, 2024

News

GEHC vs. BSX: Which Stock Is the Better Value Option?
BSX, GEHC
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?

Read More
image for news GEHC vs. BSX: Which Stock Is the Better Value Option?
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.

Read More
image for news GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
GEHC
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP & CFO Peter J.

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
GEHC
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More
image for news Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
GEHC
Published: July 30, 2025 by: Investopedia
Sentiment: Positive

GE HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year.

Read More
image for news GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
GEHC
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1 per share a year ago.

Read More
image for news GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.
GEHC
Published: July 30, 2025 by: Barrons
Sentiment: Positive

Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.

Read More
image for news GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.
GE HealthCare reports second quarter 2025 financial results
GEHC
Published: July 30, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment. We also reported strong earnings performance while leveraging our lean capabilities and demonstrating progress on tariff mitigation. Overall, we believe.

Read More
image for news GE HealthCare reports second quarter 2025 financial results
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
GEHC
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Neutral

GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.

Read More
image for news Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
GEHC
Published: July 24, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high-image quality and optimize efficiency in highly demanding environments while enhancing access and affordability. X-ray exams often serve as the entry point to diagnostic imaging, accounting for 60% of all imaging studies conducted, resulting in an ever-increasing workload for radiologists and techno.

Read More
image for news GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom
GEHC
Published: July 21, 2025 by: Seeking Alpha
Sentiment: Positive

GE HealthCare Technologies is one of the leaders in the healthcare sector, with a strong position in the global molecular imaging market. GE HealthCare's Pharmaceutical Diagnostics segment's EBIT was $205 million in Q1 2025, up 15.2% year over year. I expect it to rise to $245 million in Q2, driven by increased sales of Vizamyl, which is used to prescribe anti-amyloid drugs for the treatment of Alzheimer's disease.

Read More
image for news GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, GEHC, JNJ
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive

BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.

Read More
image for news 3 AI-Driven Medical Device Stocks to Watch in 2025
SNN vs. GEHC: Which Stock Is the Better Value Option?
GEHC, SNN
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors?

Read More
image for news SNN vs. GEHC: Which Stock Is the Better Value Option?
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
GEHC
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.

Read More
image for news GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
GEHC
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.

Read More
image for news GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
GEHC
Published: June 23, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare's commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana. As cardiovascular disease (CVD) continues to rise globally,i the need for advanced diagnostic technologies becomes increasingly critical. GE HealthCare's molecular imaging technologies – including positron emission tomograp.

Read More
image for news GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
GEHC
Published: June 19, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. “PET/CT has revolutionized the way we understand and treat disease by allowing us to visu.

Read More
image for news Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
GEHC
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Neutral

GEHC expands its bkPortfolio with the AI-powered bkActiv S Series to advance ultrasound-guided procedures.

Read More
image for news GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
GEHC Stock Declines Despite Expansion in Precision Care Capabilities
GEHC
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Neutral

GE HealthCare integrates proprietary algorithms into MIM Encore to advance digital imaging and workflow precision.

Read More
image for news GEHC Stock Declines Despite Expansion in Precision Care Capabilities
GE HealthCare: The Demand Is Just Too Strong To Ignore
GEHC
Published: June 04, 2025 by: Seeking Alpha
Sentiment: Positive

GE HealthCare's diverse business model, strong demand, and leadership in key segments position it well for long-term growth, especially with an aging population tailwind. Recent tariff volatility has pressured margins and guidance, but GEHC's global supply chain efficiency and margin recovery potential remain attractive for patient investors. Valuation is compelling at 17x forward PE, with buybacks and robust demand supporting an 18% CAGR outlook to 2029, signaling strong upside potential.

Read More
image for news GE HealthCare: The Demand Is Just Too Strong To Ignore
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks
GEHC, NVDA, PTC, VRT
Published: June 04, 2025 by: The Motley Fool
Sentiment: Neutral

Nvidia's (NVDA 0.51%) recent earnings report boosted the market and alleviated concerns about any slowdown in artificial intelligence (AI) and data-center-related spending. That's great news for Nvidia and other frontline players in the AI/data center industry.

Read More
image for news 3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
GEHC, LNTH
Published: June 02, 2025 by: PRNewsWire
Sentiment: Neutral

BOCA RATON, Fla. , June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp.

Read More
image for news PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
GEHC
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.

Read More
image for news GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GEHC
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart diagnostics for children with safer imaging.

Read More
image for news GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech
GEHC
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive

GE HealthCare unveils SIGNA Sprint MRI, a high-performance 1.5T system designed to boost diagnostic accuracy, accelerate imaging, and advance cardiac and cancer care.

Read More
image for news GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
GEHC
Published: May 02, 2025 by: Business Wire
Sentiment: Neutral

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen.

Read More
image for news ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
GE Healthcare sees tariffs costing $500 million in 2025, then much less next year
GEHC
Published: April 30, 2025 by: Market Watch
Sentiment: Negative

GE Healthcare sees bilateral China tariffs accounting for most of the expected tariff cost, or roughly 75%.

Read More
image for news GE Healthcare sees tariffs costing $500 million in 2025, then much less next year
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive

GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.

Read More
image for news GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript
GEHC
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joanne Wuensch - Citi Craig Bijou - BofA Securities Anthony Petrone - Mizuho Financial Group Operator Good day, and thank you for standing by. Welcome to the GE HealthCare First …

Read More
image for news GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript
Tariffs Weigh on GE HealthCare Outlook
GEHC
Published: April 30, 2025 by: The Motley Fool
Sentiment: Negative

Here's our initial take on GE HealthCare's (GEHC 3.14%) first-quarter financial report.

Read More
image for news Tariffs Weigh on GE HealthCare Outlook

About GE HealthCare Technologies Inc. (GEHC)

  • IPO Date 2022-12-15
  • Website https://www.gehealthcare.com
  • Industry Medical - Healthcare Information Services
  • CEO Peter J. Arduini
  • Employees 53000

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.